These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 7685386

  • 1. Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
    Rutter JJ, Auerbach SB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1319-24. PubMed ID: 7685386
    [Abstract] [Full Text] [Related]

  • 2. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation.
    Rutter JJ, Gundlah C, Auerbach SB.
    Synapse; 1995 Jul; 20(3):225-33. PubMed ID: 7570354
    [Abstract] [Full Text] [Related]

  • 3. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.
    Rutter JJ, Gundlah C, Auerbach SB.
    Neurosci Lett; 1994 Apr 25; 171(1-2):183-6. PubMed ID: 8084487
    [Abstract] [Full Text] [Related]

  • 4. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
    Rollema H, Clarke T, Sprouse JS, Schulz DW.
    J Neurochem; 1996 Nov 25; 67(5):2204-7. PubMed ID: 8863532
    [Abstract] [Full Text] [Related]

  • 5. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
    Gundlah C, Martin KF, Heal DJ, Auerbach SB.
    J Pharmacol Exp Ther; 1997 Nov 25; 283(2):581-91. PubMed ID: 9353373
    [Abstract] [Full Text] [Related]

  • 6. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM, Kang TB, Hjorth S, Auerbach SB.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar 25; 367(3):297-305. PubMed ID: 12644903
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
    Darmani NA.
    Pharmacol Biochem Behav; 1998 May 25; 60(1):83-90. PubMed ID: 9610928
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ, Coscina DV, Fletcher PJ.
    Brain Res; 1998 Jul 27; 800(1):62-8. PubMed ID: 9685586
    [Abstract] [Full Text] [Related]

  • 11. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    Caccia S, Anelli M, Codegoni AM, Fracasso C, Garattini S.
    Br J Pharmacol; 1993 Sep 27; 110(1):355-9. PubMed ID: 7693282
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C, Hyttel J.
    Eur J Pharmacol; 1994 Nov 03; 264(3):241-7. PubMed ID: 7698161
    [Abstract] [Full Text] [Related]

  • 14. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M, Moser C, Lazzarini C, Vecchiato E, Crespi F.
    Exp Brain Res; 2002 Mar 03; 143(2):191-7. PubMed ID: 11880895
    [Abstract] [Full Text] [Related]

  • 15. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.
    Kreiss DS, Lucki I.
    J Pharmacol Exp Ther; 1995 Aug 03; 274(2):866-76. PubMed ID: 7636750
    [Abstract] [Full Text] [Related]

  • 16. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN, Greenslade RG, Cooper J.
    Eur J Pharmacol; 2001 Nov 30; 432(1):19-27. PubMed ID: 11734183
    [Abstract] [Full Text] [Related]

  • 17. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine.
    Tao R, Auerbach SB.
    J Neurochem; 1994 Aug 30; 63(2):517-24. PubMed ID: 7518500
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.
    Sprouse J, Clarke T, Reynolds L, Heym J, Rollema H.
    Neuropsychopharmacology; 1996 Apr 30; 14(4):225-31. PubMed ID: 8924190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
    Tao R, Ma Z, Auerbach SB.
    J Pharmacol Exp Ther; 2000 Aug 30; 294(2):571-9. PubMed ID: 10900234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.